"Evaluation of Orally Administered mTOR inhibitor Rapamycin in Dogs in the Adjuvant Setting with Osteosarcoma"
This is the parallel arm to COTC022: SOC in dogs with Osteosarcoma that was previously uploaded to the ICDC
Clinical data for 152 dogs. mRNAseq for 93 dogs
Status: Fully loaded on the Dev environment. Testing pending.
UBC03
"Transcriptomic analyses of early stage bladder cancer in Scottish Terriers detected through screening"
Purdue University
19 cases
Status: Recently met with submitters for a final review of template-based loading files. Additional edits were requested and new versions are pending from the submitter.
OSA02
"Immune Pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma"
Colorado State University
108 cases
Status: Template-based loading files have been received and reviewed and there is a call set up to resolve minor issues
PRECINCT01
"Inhaled IL-15 Immunotherapy for Treatment of Lung Metastases"
UC Davis
21 cases
Status: Pathology reports and adverse event data have been indexed by DCF, the study is pending testing by the ICDC team
PRECINCT02
"Novel treatments for Diffuse large B cell lymphoma (DLBCL) in dogs"
Tufts University
49 cases
Status: All clinical data has been submitted. Validation errors are pending fixes. Genomics data to be submitted.
PANCAN01
"Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds"